In people with nociplastic dominant chronic pain is multi-disciplinary pain management plus motivational interviewing more effective than multi-disciplinary pain management alone for improving pain self-efficacy and pain interference: a randomised controlled trial

a Trobe University0 个研究点目标入组 184 人开始时间: 2022年6月14日最近更新: 2024年4月22日

适应症

试验速览

暂无简介。

•On completion of baseline assessment, physiotherapists will discuss participation in the trial if participants meet the following inclusion criteria:
•i.have a primary complaint of chronic musculoskeletal pain (of greater than 3 months duration)
•ii.are presumed to have a pain type of nociplastic dominant pain;
•iii.were referred for a multidisciplinary pain management program;
•iv.are aged between 18 and 75 years;
•v.have sufficient fluency in English to complete all baseline and follow up questionnaires;
•vi.have a Pain Disability Questionnaire score measure of disability of at least 50/150; and a Numerical Pain Rating Scale score of at least 3/10, to ensure that Pain Management was indicated and that there was sufficient scope for improvement to be demonstrated.

•Participants will not be approached for consent if any of the following exclusion criteria are met, but reasons for exclusion will be recorded:
•i.red flag pathologies unsuitable for pain management (active cancer, signs of cauda equina syndrome based on bladder or bowel disturbance, risk of spinal fracture, signs of potential infection, systemic inflammatory disease
•ii.chronic cancer, pelvic or neuropathic (eg post herpatic neuralgia) pain;
•iii.recent or pending surgery for the pain condition;
•iv.pregnancy or childbirth within the last 6 months;
•v.injections for the pain problem within the last 6 weeks, as we wish to study treatment effects independent to the effects of such procedures;
•vi.have already received multi-disciplinary pain management for the main pain problem within the last 2 years, to avoid contamination.

发起方

a Trobe University